Studies of Disorders With Increased Susceptibility to Fungal Infections
NCT01222741 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 850
Last updated 2026-05-22
Summary
Background:
\- Researchers are interested in studying disorders that make individuals more susceptible to fungal infections, specifically infections with the Candida yeast. These disorders are often related to problems with the immune system and may have genetic factors, which suggests that researchers should study not only the individual with the disorder, but also his or her first- and second-degree relatives (such as parents, siblings, children, and first cousins). To provide material for future research, individuals with immune disorders and their first- and second-degree relatives will be asked to provide blood and other samples for testing and comparison with samples taken from healthy volunteers with no history of immune disorders.
Objectives:
\- To collect blood and other biological samples to study immune disorders that make individuals more susceptible to fungal infections.
Eligibility:
* Individuals of any age who have abnormal immune function characterized by recurrent or unusual fungal infections, recurrent or chronic inflammation, or other types of immune dysfunction.
* First- or second-degree genetically related family members (limited to mother, father, siblings, grandparents, children, aunts, uncles, and first cousins).
* Healthy volunteers at least 18 years of age (for comparison purposes).
Design:
* Participants will provide blood samples and buccal (cells from the inside of the mouth near the cheek) samples.
* Participants with immune disorders will also be asked to provide urine samples, saliva or mucosal samples, or skin tissue biopsies, and may also have imaging studies (such as x-rays) to collect information for research.
* Samples may be collected at the National Institutes of Health or at other clinical locations for the samples to the sent to the National Institutes of Health.
* No treatment will be provided as part of this protocol....
Conditions
- Fungal Infections
- Primary Immune Deficiencies
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Sergio D Rosenzweig, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-01-07
Countries
- United States
Study Locations
More Related Trials
-
Study of Micafungin in Patients With Invasive Candidiasis or Candidemia
NCT00105144 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
NCT05235711 ·Status: COMPLETED
-
Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection
NCT00001702 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia
NCT01982071 ·Status: TERMINATED ·Phase: PHASE4
-
Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis
NCT00923832 ·Status: COMPLETED
-
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings
NCT00095316 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
An Observational Study of Fungal Biomarkers (MK-0000-089)
NCT00854607 ·Status: COMPLETED
-
Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
NCT01686607 ·Status: COMPLETED
-
Anidulafungin Versus Fluconazole in the Treatment of Candidemia
NCT00058682 ·Status: COMPLETED ·Phase: PHASE3
-
Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections
NCT06387667 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)
NCT00083343 ·Status: COMPLETED ·Phase: PHASE2
-
A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)
NCT01174147 ·Status: COMPLETED
-
Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis
NCT03421002 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
NCT03262584 ·Status: COMPLETED
-
A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal Infections
NCT02678598 ·Status: COMPLETED
-
Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease
NCT00001280 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS
NCT00002294 ·Status: COMPLETED ·Phase: NA
-
Clinical Impact of Fungal Domestic Environmental Exposure on COPD Patients
NCT02318524 ·Status: COMPLETED
-
Microbiota in Skin and Mucosa of Patients With Inflammatory Skin Diseases
NCT04215458 ·Status: UNKNOWN ·Phase: NA
-
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
NCT00445952 ·Status: COMPLETED
-
Investigation of Clinical Relevance of β-D-Glucan Tests in Patients With Invasive Fungal Infection (IFI)
NCT01490138 ·Status: UNKNOWN
-
Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility
NCT01077336 ·Status: COMPLETED
-
The Relationship Between Morphology and Virulent Genes of Candida Albicans and Clinical Aspects, Surveillance of Fungemia
NCT01211041 ·Status: UNKNOWN
-
Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections
NCT02492594 ·Status: COMPLETED